Bodo, Juraj <br/><br/>
Acquired resistance to venetoclax (ABT-199) in t(14;18) positive lymphoma cells.  [electronic resource] 

 -  Oncotarget  Oct 2016 
 - 70000-70010 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.12132  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis--drug effects<br/>Autophagy--drug effects<br/>Bcl-2-Like Protein 11--analysis<br/>Bridged Bicyclo Compounds, Heterocyclic--therapeutic use<br/>Cell Proliferation--drug effects<br/>Chromosomes, Human, Pair 14<br/>Chromosomes, Human, Pair 18<br/>Drug Resistance, Neoplasm<br/>Extracellular Signal-Regulated MAP Kinases--antagonists & inhibitors<br/>Humans<br/>Lymphoma, Follicular--drug therapy<br/>Mice<br/>Phosphoinositide-3 Kinase Inhibitors<br/>Proto-Oncogene Proteins c-akt--antagonists & inhibitors<br/>Proto-Oncogene Proteins c-bcl-2--analysis<br/>Sulfonamides--therapeutic use<br/>Translocation, Genetic